463 related articles for article (PubMed ID: 17430797)
21. Thymosin administration in autoimmune disorders.
Lavastida MT; Goldstein AL; Daniels JC
Thymus; 1981 Feb; 2(4-5):287-95. PubMed ID: 6972106
[TBL] [Abstract][Full Text] [Related]
22. Update on the role of Interleukin 17 in rheumatologic autoimmune diseases.
Konya C; Paz Z; Apostolidis SA; Tsokos GC
Cytokine; 2015 Oct; 75(2):207-15. PubMed ID: 26028353
[TBL] [Abstract][Full Text] [Related]
23. Biologics in the treatment of rheumatoid arthritis and ankylosing spondylitis.
Braun J; Kalden JR
Clin Exp Rheumatol; 2009; 27(4 Suppl 55):S164-7. PubMed ID: 19822066
[TBL] [Abstract][Full Text] [Related]
24. Reversing bacteria-induced vitamin D receptor dysfunction is key to autoimmune disease.
Waterhouse JC; Perez TH; Albert PJ
Ann N Y Acad Sci; 2009 Sep; 1173():757-65. PubMed ID: 19758226
[TBL] [Abstract][Full Text] [Related]
25. Serum levels of cartilage oligomeric matrix protein are elevated in rheumatoid arthritis, but not in inflammatory rheumatic diseases such as psoriatic arthritis, reactive arthritis, Raynaud's syndrome, scleroderma, systemic lupus erythematosus, vasculitis and Sjögren's syndrome.
Skoumal M; Haberhauer G; Feyertag J; Kittl EM; Bauer K; Dunky A
Arthritis Res Ther; 2004; 6(2):73-4. PubMed ID: 15059267
[No Abstract] [Full Text] [Related]
26. The role of the laboratory in rheumatology. Lymphocytes.
Russell AS; Edelman J
Clin Rheum Dis; 1983 Apr; 9(1):117-34. PubMed ID: 6603321
[No Abstract] [Full Text] [Related]
27. Expression of CD5 and CD23 on B cells of patients with rheumatoid arthritis, systemic lupus erythematosus and Sjögren's syndrome. Relationship with disease activity and treatment.
Ebo D; DeClerck LS; Bridts CH; Stevens WJ
In Vivo; 1994; 8(4):577-80. PubMed ID: 7534494
[TBL] [Abstract][Full Text] [Related]
28. Potential target of infliximab in autoimmune and inflammatory diseases.
Atzeni F; Doria A; Carrabba M; Turiel M; Sarzi-Puttini P
Autoimmun Rev; 2007 Sep; 6(8):529-36. PubMed ID: 17854744
[TBL] [Abstract][Full Text] [Related]
29. Anti-B cell antibody therapies for inflammatory rheumatic diseases.
Faurschou M; Jayne DR
Annu Rev Med; 2014; 65():263-78. PubMed ID: 24160940
[TBL] [Abstract][Full Text] [Related]
30. [Effectiveness and safety of biological therapy with adalimumab].
Fehér J; Lengyel G
Orv Hetil; 2009 Jun; 150(26):1215-22. PubMed ID: 19546078
[TBL] [Abstract][Full Text] [Related]
31. Relationship of Sjögren's syndrome to other connective tissue and autoimmune disorders.
Theander E; Jacobsson LT
Rheum Dis Clin North Am; 2008 Nov; 34(4):935-47, viii-ix. PubMed ID: 18984413
[TBL] [Abstract][Full Text] [Related]
32. Immunologic and clinical effects of cytotoxic drugs used in the treatment of rheumatoid arthritis and systemic lupus erythematosus.
Fox DA; McCune WJ
Concepts Immunopathol; 1989; 7():20-78. PubMed ID: 2676180
[No Abstract] [Full Text] [Related]
33. Effective use of autoantibody tests in the diagnosis of systemic autoimmune disease.
Lyons R; Narain S; Nichols C; Satoh M; Reeves WH
Ann N Y Acad Sci; 2005 Jun; 1050():217-28. PubMed ID: 16014537
[TBL] [Abstract][Full Text] [Related]
34. Pulmonary manifestations of the collagen vascular diseases.
Wiedemann HP; Matthay RA
Clin Chest Med; 1989 Dec; 10(4):677-722. PubMed ID: 2689071
[TBL] [Abstract][Full Text] [Related]
35. [Systemic autoimmune disorders and pregnancy].
Kiss E; Kiss CG; Poór G
Orv Hetil; 2011 Oct; 152(43):1715-23. PubMed ID: 21983397
[TBL] [Abstract][Full Text] [Related]
36. Anti-tumor necrosis factor therapy: 6 year experience of a single center in northern Israel and possible impact of health policy on results.
Braun-Moscovici Y; Markovits D; Rozin A; Toledano K; Nahir AM; Balbir-Gurman A
Isr Med Assoc J; 2008 Apr; 10(4):277-81. PubMed ID: 18548981
[TBL] [Abstract][Full Text] [Related]
37. [Cardiac involvement in systemic autoimmune disease].
Dropiński J; Szczeklik W; Rubiś P
Pol Arch Med Wewn; 2003 Apr; 109(4):375-81. PubMed ID: 12931489
[TBL] [Abstract][Full Text] [Related]
38. Recent advances in rheumatology: biological agents for the treatment of rheumatoid arthritis, the progression of psoriatic arthritis, autoantibodies in systemic lupus erythematosus.
Finucane KA; Archer CB
Clin Exp Dermatol; 2005 Mar; 30(2):201-4. PubMed ID: 15725261
[No Abstract] [Full Text] [Related]
39. T cell subsets and their role in the pathogenesis of rheumatic disease.
Gizinski AM; Fox DA
Curr Opin Rheumatol; 2014 Mar; 26(2):204-10. PubMed ID: 24445478
[TBL] [Abstract][Full Text] [Related]
40. [Tumour necrosis factor antagonists: infliximab, adalimumab and etanercept].
Breedveld FC
Ned Tijdschr Geneeskd; 2005 Oct; 149(41):2273-7. PubMed ID: 16240851
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
